Breast Cancer Clinical Trial

Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

Summary

The purpose of this study is to measure the level of AlloMaxâ„¢ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM implants and agree to participate will be included in this study.

Exclusion Criteria:

Patients who do not agree to be included in the study.

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT01679223

Recruitment Status:

Unknown status

Sponsor:

University of Nevada, Las Vegas

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Nevada School of Medicine
Las Vegas Nevada, 89102, United States More Info
Sherree Mounts, LPN
Contact
702-671-5117
[email protected]
Kayvan Taghipour-Khiabani, M.D.
Principal Investigator
William A Zamboni, M.D.
Sub-Investigator
Richard C Baynosa, M.D.
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT01679223

Recruitment Status:

Unknown status

Sponsor:


University of Nevada, Las Vegas

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider